Nisha I Parikh1, Barbara Laria2, Gregory Nah1, Meghali Singhal1,3, Eric Vittinghoff1, Cassandra Vieten4, Naomi Stotland4, Kimberly Coleman-Phox4, Nancy Adler4, Michelle A Albert1,5, Elissa Epel4. 1. Cardiovascular Division, Department of Medicine, University of California San Francisco, San Francisco, California, USA. 2. School of Public Health, University of California at Berkeley, Berkeley, California, USA. 3. Department of Integrative Biology, University of California at Berkeley, Berkeley, California, USA. 4. Department of Family Medicine and Public Health, University of California, San Diego, San Diego, California, USA. 5. Nurture Center, University of California San Francisco, San Francisco, California, USA.
Abstract
Background: Having a pregnancy complicated by hypertensive disorders of pregnancy (HDP) and/or having a small or preterm baby put a woman at risk for later cardiovascular disease (CVD). It is uncertain if higher maternal CVD risk factors (reflected by increased peripartum CVD biomarker levels) account for this risk, or if experiencing a complicated pregnancy itself increases a woman's CVD risk (reflected by an increase in biomarker trajectories from early pregnancy to postpartum). Methods: We conducted a secondary analysis of an 8-week mindful eating and stress reduction intervention in 110 pregnant women. We used mixed linear regression analysis to compare CVD biomarker levels and trajectories, between women with and without a CVD-related pregnancy complication (including HDP [gestational hypertension or preeclampsia] or having a small for gestational age [<10th percentile] or preterm [<37 weeks] baby), at three times: (1) 12-20 weeks of gestation, (2) 3 months postpartum, and (3) 9 months postpartum. CVD biomarkers studied included serum glucose, insulin, homeostasis model assessment of insulin resistance (HOMA-IR), body mass index (BMI), blood pressure (BP), interleukin-6 (IL-6), tumor necrosis factor, and lipids. We adjusted for age, maternal smoking, prepregnancy BMI, BP, age × time, and BMI × time. Results: Women had a mean age of 28 years (standard deviation [SD] 6), mean prior pregnancies of 0.8 (SD 1.0), and 22 women had one or more CVD-related pregnancy complications. HOMA-IR, diastolic BP, triglyceride, high-density lipoprotein cholesterol, and IL-6 average levels, but not trajectories, differed among women with complicated versus normal pregnancy (all p values were ≤0.04). Peripartum glucose and systolic BP trajectories were statistically greater in complicated versus normal pregnancies (p values were 0.008 and 0.01, respectively). Conclusion: We conclude that the experience of a complicated pregnancy in addition to elevated CVD risk factor levels may both increase a woman's risk of future CVD. ClinicalTrials.gov Identifier: NCT01307683.
Background: Having a pregnancy complicated by hypertensive disorders of pregnancy (HDP) and/or having a small or preterm baby put a woman at risk for later cardiovascular disease (CVD). It is uncertain if higher maternal CVD risk factors (reflected by increased peripartum CVD biomarker levels) account for this risk, or if experiencing a complicated pregnancy itself increases a woman's CVD risk (reflected by an increase in biomarker trajectories from early pregnancy to postpartum). Methods: We conducted a secondary analysis of an 8-week mindful eating and stress reduction intervention in 110 pregnant women. We used mixed linear regression analysis to compare CVD biomarker levels and trajectories, between women with and without a CVD-related pregnancy complication (including HDP [gestational hypertension or preeclampsia] or having a small for gestational age [<10th percentile] or preterm [<37 weeks] baby), at three times: (1) 12-20 weeks of gestation, (2) 3 months postpartum, and (3) 9 months postpartum. CVD biomarkers studied included serum glucose, insulin, homeostasis model assessment of insulin resistance (HOMA-IR), body mass index (BMI), blood pressure (BP), interleukin-6 (IL-6), tumornecrosis factor, and lipids. We adjusted for age, maternal smoking, prepregnancy BMI, BP, age × time, and BMI × time. Results:Women had a mean age of 28 years (standard deviation [SD] 6), mean prior pregnancies of 0.8 (SD 1.0), and 22 women had one or more CVD-related pregnancy complications. HOMA-IR, diastolic BP, triglyceride, high-density lipoprotein cholesterol, and IL-6 average levels, but not trajectories, differed among women with complicated versus normal pregnancy (all p values were ≤0.04). Peripartum glucose and systolic BP trajectories were statistically greater in complicated versus normal pregnancies (p values were 0.008 and 0.01, respectively). Conclusion: We conclude that the experience of a complicated pregnancy in addition to elevated CVD risk factor levels may both increase a woman's risk of future CVD. ClinicalTrials.gov Identifier: NCT01307683.
Authors: Lorene A Temming; Methodius G Tuuli; Molly J Stout; George A Macones; Alison G Cahill Journal: Am J Perinatol Date: 2016-02-23 Impact factor: 1.862
Authors: Mieke C E Hooijschuur; Chahinda Ghossein-Doha; Salwan Al-Nasiry; Marc E A Spaanderman Journal: Am J Obstet Gynecol Date: 2015-05-22 Impact factor: 8.661
Authors: Zakia Sultana; Kaushik Maiti; John Aitken; Jonathan Morris; Lee Dedman; Roger Smith Journal: Am J Reprod Immunol Date: 2017-02-27 Impact factor: 3.886
Authors: Elisabeth B Magnussen; Lars J Vatten; Kirsti Myklestad; Kjell Å Salvesen; Pål R Romundstad Journal: Am J Obstet Gynecol Date: 2011-03-31 Impact factor: 8.661
Authors: Lauren J Tanz; Jennifer J Stuart; Stacey A Missmer; Eric B Rimm; Jennifer A Sumner; Mary A Vadnais; Janet W Rich-Edwards Journal: Pregnancy Hypertens Date: 2018-04-18 Impact factor: 2.899
Authors: Corrie Macdonald-Wallis; Debbie A Lawlor; Abigail Fraser; Margaret May; Scott M Nelson; Kate Tilling Journal: Hypertension Date: 2012-04-23 Impact factor: 10.190
Authors: Mara E Murray Horwitz; Molly A Fisher; Christine A Prifti; Janet W Rich-Edwards; Christina D Yarrington; Katharine O White; Tracy A Battaglia Journal: J Gen Intern Med Date: 2022-01-06 Impact factor: 5.128
Authors: Aleksander L Hansen; Marc Meller Søndergaard; Mark A Hlatky; Eric Vittinghof; Gregory Nah; Marcia L Stefanick; JoAnn E Manson; Leslie V Farland; Gretchen L Wells; Morgana Mongraw-Chaffin; Erica P Gunderson; Linda Van Horn; Robert A Wild; Buyun Liu; Aladdin H Shadyab; Matthew A Allison; Simin Liu; Charles B Eaton; Michael C Honigberg; Nisha I Parikh Journal: JAMA Netw Open Date: 2021-12-01